arginyl-glycyl-aspartic acid has been researched along with fumagillin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caruthers, SD; Lanza, GM; Robertson, JD; Schmieder, AH; Wickline, SA; Williams, TA; Zhang, H | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and fumagillin
Article | Year |
---|---|
Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.
Topics: Angiogenesis Inhibitors; Animals; Breast Neoplasms; Cell Adhesion; Contrast Media; Cyclohexanes; Fatty Acids, Unsaturated; Fibronectins; Flow Cytometry; Integrin alphaVbeta3; Magnetic Resonance Angiography; Mice; Microscopy, Confocal; Nanoparticles; Neoplasm Transplantation; Neovascularization, Pathologic; Oligopeptides; Particle Size; Receptors, Vitronectin; Sesquiterpenes | 2008 |